Evidence map›Paper›PMID 29606080›Full record

ArticleRedox report : communications in free radical research2018

Optimization of a diagnostic platform for oxidation-reduction potential (ORP) measurement in human plasma.

David Polson, Nuria Villalba, Kalev Freeman

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David Polsona Department of Surgery , Larner College of Medicine, University of Vermont , Burlington , VT , USA.ORCID http://orcid.org/0000-0002-1886-3037
Nuria Villalbaa Department of Surgery , Larner College of Medicine, University of Vermont , Burlington , VT , USA.
Kalev Freemana Department of Surgery , Larner College of Medicine, University of Vermont , Burlington , VT , USA.ORCID http://orcid.org/0000-0003-4817-2955
University of Vermont · US

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
Impact of Trauma and its Products on Vascular Endothelial FunctionR01GM123010 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI FREEMAN, KALEV · 2017 to 2021
$1.5M
NHLBI NIH HHS UM1 HL120877NIGMS NIH HHS R01 GM123010
6 · The paper itself

Abstract

objectivesOxidation-reduction potential (ORP) measurement can demonstrate the extent of oxidative stress in patients with severe illness and/or injury. A novel ORP diagnostic platform using disposable sensors (RedoxSYS) has been validated by comparison to mass spectrometry, but the optimal methods of sample handling for best performance of the device have not been described.

methodsWe sought to optimize ORP measurement in human plasma under controlled conditions. We hypothesized that the anticoagulant, freeze-thawing, and storage duration would influence measured ORP levels.

resultsThe platform was sensitive to exogenous oxidation with hydrogen peroxide and reduction with ascorbic acid. Plasma anticoagulated with heparin was more sensitive to differences in ORP than plasma prepared in citrate. ORP measurements decreased slightly after a freeze-thaw cycle, but once frozen, ORP was stable for up to one month. DISCUSSION: We confirm that ORP detects oxidative stress in plasma samples. Optimal measurement of plasma ORP requires blood collection in heparin anticoagulant tubes and immediate analysis without a freeze-thaw cycle.

Indexed as

AnticoagulantsAscorbic AcidHeparinHumansHydrogen PeroxideMass SpectrometryOxidation-ReductionOxidative StressReactive Oxygen SpeciesAnticoagulantsAscorbic AcidHeparinHydrogen PeroxideReactive Oxygen SpeciesOxidation–reduction potentialoxidative stressplasma

Identifiers

PMID29606080
PMCPMC6748793
OpenAlexW2795056953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.